Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

nts made in this news release contain information that is not historical, these statements are essentially forward- looking and, as such, are subject to risks and uncertainties, including the difficulty of predicting FDA filings and approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, uncertainty of patent litigation filed against the Company, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), such as the company's reports on Form 10-K, Form 10-Q and Form 8-K, and amendments thereto. Any forward-looking statements included in this press release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.

PAR PHARMACEUTICAL COMPANIES, INC.

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2007 AND 2006

(In Thousands, Except Share Data)

December 31, December 31,

2007 2006

ASSETS (Restated)

Current assets:

Cash and cash equivalents $200,132 $120,991

Available for sale debt and

marketable equity securities 85,375 92,120

Accounts receivable, net 64,182 99,043

Inventories 84,887 106,322

Prepaid expenses and other

current assets 14,294 15,833

Deferred income tax
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire-FirstCall/--ParPharmaceutic...tsofits"ModifiedDutchAuction"tenderoffer,inwhichPa...eprincipalamount,oruptoapproximately82.7%,ofitsout...e2010. ,, BasedonthecountbyAmericanStockTransfe...fer,$30,805,000aggregateprincipalamountoftheNotesw...
(Date:11/25/2009)...nge by reducing carbon dioxide and other greenhous... in addition to reducing the risk of climate chang...o a series of six papers appearing today (Wed., No...o University of California, Berkeley, authors of t...ironmental health, and Michael Jerrett, associate ...
(Date:11/25/2009)...ovascular disease may make a case for population-w...Y, Nov. 25 (HealthDay News) -- It,s known that eat...igh blood pressure. Now there,s confirmation of a ...nificantly greater risk of cardiovascular disease ...5 online edition of BMJ found that a difference ...
(Date:11/25/2009)... Thirty-seven million Americans are afflicted w...sive technology for treating chronic sinus inflamm...ckson, Miss. The Balloon Sinuplasty™ system ...oon to quickly open and expand blocked sinuses. ,... -- A clinically proven, minimally invasive techno...
(Date:11/25/2009)...r25/PRNewswire/-- , -LatestSurveyFromTheITJob...gativeImpactonourHealth , 81percentofITprosbe...asurvey[1]conductedbyTheITJobBoard, http://www.th...,percent),believetheimpactisanegativeone. , M...ingshave,increasedoverthelastyear-sincetherecessio...
Breaking Medicine News(10 mins):Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 3Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 3Health News:It's Official, Work is Bad for Our Health! 2
...million dollar NIH funding advances study St...rates, MINNEAPOLIS, Oct. 13 Advanced Circulatory...m ) announced today that it has received,an additi...erience cardiac arrest outside a hospital. Parts o...
...S, Md., Oct. 13 The National Coalition for,Qualit...ting concerns over,the National CT Colonography St...nal of Medicine. The evidence must be closely eval...lonoscopy,remains the "Gold Standard" for colorect...
..., Fla., Oct. 13 The 2008 NCPA Digest,sponsored by...10th Annual,Convention. The Digest has been publis...st comprehensive portrait of the financial state o...,drug program had played a leading role in reducin...
...ys deficiency persists even after weekly doses up ...Oct. 13 (HealthDay News) -- Existing guidelines fo...ystic fibrosis are too low and put patients at hig...). Nearly half the children were vitamin D-deficie...
... AtlantaJobs.com and numerous ne...nch of www.AtlantaJobs.com . AtlantaJobs.com is ...g local employers and jobseekers in the metro Atla...ficial launch of AtlantaJobs.com is the newest o...
... Birdstep Technology,s high avai...ilable for ENEA,s carrier grade OSE RTOS. , ... 2008 -- Birdstep Technology (OSE: BIRD) today ann...DM Server supported platforms., , ,"We recogn...
Other Medicine News:Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3Health News:Vitamin D Guidelines Too Low for Cystic Fibrosis Kids 2Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2Health News:Birdstep Technology Adds ENEA's OSE RTOS to the List of Operating Systems Supported by Their RDM Server, Embedded Database Product 2
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, MammographyEquipment-AGlobalMarket...0164330/Mammography-Equipment---A-Global-Market-Pe...rinindustrializedaswellasdevelopingnationsisaprinc...Globally,escalatingawarenessaboutbreastcancerhasal...
(Date:11/25/2009)...SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,In...velopingproductsforminimallydisruptivesurgicaltrea...ferencecallonMonday,November30,2009,at5:30p.m.ET/2...srelativetoreimbursementfortheCompany,sproductsand...uestionandanswersession.Thedial-innumbersare1-877-...
(Date:11/25/2009)...DELFT,TheNetherlandsandJOHANNESBURG,November25/PRN...ndPyxisDiscoveryannouncedtoday,thattheyhavesigneda...s,services. , Pyxis,sworldclasscomputationalc...hiThemba,sservicedivisiontoprovidemedicinaland,syn...yxis,internationalclientnetwork.iThembaPharmaceut...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2U S Faces Shortage of Heart Surgeons 56866 1U S Faces Shortage of Heart Surgeons 56866 2U S Faces Shortage of Heart Surgeons 56866 3Ellis Island Event Celebrates Life and Liberty After Cancer 56863 1Ellis Island Event Celebrates Life and Liberty After Cancer 56863 2Ellis Island Event Celebrates Life and Liberty After Cancer 56863 3President Obama Misleads Public on Health Care for Illegal Aliens 3B Illegal Aliens Would Benefit Under H R 3200 56859 1President Obama Misleads Public on Health Care for Illegal Aliens 3B Illegal Aliens Would Benefit Under H R 3200 56859 2
... June 15 /CNW/ - Today AMADEO, one of the,first st...angiotensin receptor blockers in hypertensive pat...the European Society,of Hypertension, Milan. The ...uces proteinuria to a significantly greater extent...ults, Prof. Ellen Burgess, Foothills Hospital,in ...
...nn., June 18, 2007 /PRNewswire/ -- Today, results,... two angiotensin,receptor blockers (ARBs) in hyper...resented at the 17th annual European Meeting on,Hy...le-blind, forced titration, parallel group,multic...30/80mmHg) with type 2 diabetes and overt nephropa...
Other Medicine Technology:New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 2New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 3New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 4
...se are rigid gas permeable contact lenses used for...arily corrects nearsightedness (myopia). The patie...emoves them upon wakening. During the day, nearsig...agon CRT and Quadra RG contact lenses apply slight...
...Cath Diagnostics solves all the major challenges t...r fair market fee for each procedure includes:, ...d Certified Nuclear Medicine Technologist., New, d...t and Accessories., All procedure supplies, includ...
...sidering opening your own cath lab? Worried about...o mention the headaches of managing the ongoing bu...rovide a turnkey service leaving you free to care ...ll provide a convenient diagnostic facility for yo...
... model SP-9000 is exactly the same as the model SP...has a separate Pachy mode. This mode has its own f...n all directions. It allows you to select an area ...s built-in software to calculate averages of multi...
Medicine Products: